← Back to Search

INTEGRATE-D for Diabetes

N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary care practices are affiliated with the Oregon Rural Practice-Based Network (ORPRN), at time of recruitment.
Primary care practices must be located in Oregon.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline screening at 15 months
Awards & highlights

Study Summary

This study is evaluating whether a package of implementation strategies can help primary care practices integrate medical and psychosocial care for patients with type 2 diabetes.

Eligible Conditions
  • Diabetes
  • Primary Care
  • Mental Health

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 15 months, post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 15 months, post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of intervention
Appropriateness of the intervention
Feasibility of the intervention
Secondary outcome measures
Hemoglobin A1c
Patient Health Questionnaire-9

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
INTEGRATE-D is a step-by-step blueprint that will assist practices with employing American Diabetes Association recommendations for integrating medical and psychosocial care. INTEGRATE-D consists of a set of implementation strategies that enable clinical teams to put evidence-based care in place. The intervention consists of training and education; audit and feedback materials; a facilitation implementation protocol; and health information technology support materials.
Group II: Control ArmActive Control1 Intervention
Usual care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
INTEGRATE-D
2020
N/A
~300

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
6,845,735 Total Patients Enrolled
3 Trials studying Diabetes
376 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~63 spots leftby Apr 2025